Additionally, in vivo blockade of this pathway in pancreatic ductal adenocarcinoma animal models significantly reduced intratumoral infiltration and suppressive activity of MDSCs, limited tumor growth, and enhanced the efficacy of PD-1/PD-L1 axis inhibitors [24]. The gene discussed is CD274; the disease is pancreatic ductal adenocarcinoma.